Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain 11/02/2020 Elaine Ruth Fletcher The novel coronavirus has been officially named by the World Health Organization as COVID-19, in the first day of a global consultation with about 400 researchers and public health experts charged with designing a coherent way forward to confront the expanding epidemic. However, as the case count rose by Tuesday afternoon to 42,747 people with […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> United States Calls For WHO Guidance On Coronavirus Travel Restrictions; US CDC Official Raises “Pandemic” Possibility 06/02/2020 Elaine Ruth Fletcher, John Zarocostas & Catherine Saez As the number of novel coronavirus infections rose again on Thursday – to 28,060 confirmed cases in China and 225 abroad – a US Centers for Disease Control official raised the possible spectre that the epidemic could become a global “pandemic” – if countries fail to take assertive action now. “While unclear how the situation […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain 11/02/2020 Elaine Ruth Fletcher The novel coronavirus has been officially named by the World Health Organization as COVID-19, in the first day of a global consultation with about 400 researchers and public health experts charged with designing a coherent way forward to confront the expanding epidemic. However, as the case count rose by Tuesday afternoon to 42,747 people with […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> United States Calls For WHO Guidance On Coronavirus Travel Restrictions; US CDC Official Raises “Pandemic” Possibility 06/02/2020 Elaine Ruth Fletcher, John Zarocostas & Catherine Saez As the number of novel coronavirus infections rose again on Thursday – to 28,060 confirmed cases in China and 225 abroad – a US Centers for Disease Control official raised the possible spectre that the epidemic could become a global “pandemic” – if countries fail to take assertive action now. “While unclear how the situation […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> United States Calls For WHO Guidance On Coronavirus Travel Restrictions; US CDC Official Raises “Pandemic” Possibility 06/02/2020 Elaine Ruth Fletcher, John Zarocostas & Catherine Saez As the number of novel coronavirus infections rose again on Thursday – to 28,060 confirmed cases in China and 225 abroad – a US Centers for Disease Control official raised the possible spectre that the epidemic could become a global “pandemic” – if countries fail to take assertive action now. “While unclear how the situation […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United States Calls For WHO Guidance On Coronavirus Travel Restrictions; US CDC Official Raises “Pandemic” Possibility 06/02/2020 Elaine Ruth Fletcher, John Zarocostas & Catherine Saez As the number of novel coronavirus infections rose again on Thursday – to 28,060 confirmed cases in China and 225 abroad – a US Centers for Disease Control official raised the possible spectre that the epidemic could become a global “pandemic” – if countries fail to take assertive action now. “While unclear how the situation […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts